NGM Post Data Channel

NASDAQ:NGM   NGM Biopharmaceuticals, Inc
I exited NGM for a 26% gain yesterday and re-entered today at $12.80. The stock appears to found a new channel following the release of interim phase 2 NASH data. This trade involves chart patterns and fundamentals. NGM is backed by Column Group L.P and Merck ( MRK ). Their data was positive. The float is very low and locked up by the above NGM shareholders. Should bounce to ~$14.0. Could break out to the $16.0 range.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.